|
Posterior Cerebellar Commissure
|
A08.186.211.132.659.800.611 |
|
|
Arginine
|
D001120 |
[An essential amino acid that is physiologically active in the L-form.
] |
|
Lysine Carboxypeptidase
|
D001121 |
[A metallocarboxypeptidase that removes C-terminal basic amino acid from peptides and proteins, with preference shown for lysine over arginine. It is a plasma zinc enzyme that inactivates bradykinin and anaphylatoxins.
] |
|
Argininosuccinate Synthase
|
D001124 |
[An enzyme of the urea cycle that catalyzes the formation of argininosuccinic acid from citrulline and aspartic acid in the presence of ATP. Absence or deficiency of this enzyme causes the metabolic disease CITRULLINEMIA in humans. EC 6.3.4.5.
] |
|
Myocardial Reperfusion
|
E04.100.700.600 |
|
|
Reperfusion
|
E04.100.700 |
|
|
Argininosuccinic Acid
|
D001125 |
[This amino acid is formed during the urea cycle from citrulline, aspartate and ATP. This reaction is catalyzed by argininosuccinic acid synthetase.
] |
|
Arginine Kinase
|
D001122 |
[An enzyme that catalyzes the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. EC 2.7.3.3.
] |
|
Argininosuccinate Lyase
|
D001123 |
[An enzyme of the urea cycle which splits argininosuccinate to fumarate plus arginine. Its absence leads to the metabolic disease ARGININOSUCCINIC ACIDURIA in man. EC 4.3.2.1.
] |
|
Rest
|
I03.450.769.647 |
|
|
Relaxation
|
I03.450.769 |
|
|
Glycochenodeoxycholic Acid
|
D04.210.500.105.225.272.150.350 |
|
|
Granuloma, Respiratory Tract
|
D015769 |
[Granulomatous disorders affecting one or more sites in the respiratory tract.
] |
|
Colles' Fracture
|
C26.404.562.356 |
|
|
Radius Fractures
|
C26.404.562 |
|
|
Mefloquine
|
D015767 |
[A phospholipid-interacting antimalarial drug (ANTIMALARIALS). It is very effective against PLASMODIUM FALCIPARUM with very few side effects.
] |
|
4-Aminopyridine
|
D015761 |
[One of the POTASSIUM CHANNEL BLOCKERS with secondary effect on calcium currents which is used mainly as a research tool and to characterize channel subtypes.
] |
|
Receptors, Opioid
|
D12.776.543.750.750.555.610 |
|
|
2-Chloroadenosine
|
D015762 |
[2-Chloroadenosine. A metabolically stable analog of adenosine which acts as an adenosine receptor agonist. The compound has a potent effect on the peripheral and central nervous system.
] |
|
Flocculation Tests
|
E05.200.812.735.645.300 |
|
